Private Trust Co. NA purchased a new position in shares of Cognex Co. (NASDAQ:CGNX) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 3,330 shares of the scientific and technical instruments company’s stock, valued at approximately $203,000.

A number of other large investors have also recently added to or reduced their stakes in CGNX. The Manufacturers Life Insurance Company raised its holdings in Cognex by 1.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 133,670 shares of the scientific and technical instruments company’s stock valued at $11,349,000 after acquiring an additional 2,551 shares in the last quarter. LMR Partners LLP acquired a new position in Cognex in the 3rd quarter valued at $8,308,000. DekaBank Deutsche Girozentrale acquired a new position in Cognex in the 3rd quarter valued at $841,000. Eagle Boston Investment Management Inc. acquired a new position in Cognex in the 3rd quarter valued at $265,000. Finally, State Street Corp raised its holdings in Cognex by 2.2% in the 2nd quarter. State Street Corp now owns 2,169,073 shares of the scientific and technical instruments company’s stock valued at $184,153,000 after acquiring an additional 45,840 shares in the last quarter. 42.10% of the stock is owned by institutional investors and hedge funds.

Cognex Co. (CGNX) opened at $68.39 on Thursday. Cognex Co. has a fifty-two week low of $32.05 and a fifty-two week high of $72.99. The company has a market capitalization of $11,840.00, a price-to-earnings ratio of 50.29 and a beta of 1.50.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings results on Monday, October 30th. The scientific and technical instruments company reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.05. Cognex had a return on equity of 23.31% and a net margin of 34.77%. The company had revenue of $259.74 million during the quarter, compared to analysts’ expectations of $255.95 million. During the same quarter in the previous year, the firm earned $0.31 EPS. Cognex’s revenue was up 75.6% on a year-over-year basis. equities research analysts anticipate that Cognex Co. will post 1.39 earnings per share for the current year.

In other news, Director Theodor Krantz sold 15,000 shares of the business’s stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $134.05, for a total transaction of $2,010,750.00. Following the completion of the transaction, the director now owns 26,250 shares of the company’s stock, valued at approximately $3,518,812.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Patrick Alias sold 5,000 shares of the business’s stock in a transaction on Monday, November 27th. The stock was sold at an average price of $143.54, for a total value of $717,700.00. The disclosure for this sale can be found here. Insiders have sold a total of 143,750 shares of company stock valued at $18,540,975 in the last three months. 5.60% of the stock is owned by insiders.

Several equities analysts have weighed in on CGNX shares. Zacks Investment Research cut Cognex from a “strong-buy” rating to a “sell” rating in a report on Tuesday, January 2nd. JPMorgan Chase & Co. cut Cognex from a “neutral” rating to an “underweight” rating and set a $62.50 price objective for the company. in a report on Wednesday, November 8th. ValuEngine cut Cognex from a “hold” rating to a “sell” rating in a report on Thursday, December 7th. Robert W. Baird lifted their price objective on Cognex from $50.00 to $62.00 and gave the company a “neutral” rating in a report on Tuesday, October 31st. Finally, BidaskClub raised Cognex from a “hold” rating to a “buy” rating in a report on Wednesday, January 10th. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company. Cognex currently has an average rating of “Hold” and a consensus price target of $60.17.

WARNING: This piece was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.watchlistnews.com/private-trust-co-na-purchases-new-holdings-in-cognex-co-cgnx/1812113.html.

Cognex Profile

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.